PGR and breast cancer: As a surrogate, histopathology and immunohistochemistry (IHC) for estrogen receptor (ER), progesterone receptor (PgR), HER2, and Ki67 proliferation index is commonly used to describe the different BC groups and provides prognostic information to facilitate treatment decision making.